OKG Capital
Investor profile
Venture capital
OKG Capital has backed 3 European tech companies across 3 funding rounds between 2023 and 2026, joining rounds totalling €17M. Most active in Healthtech and Cleantech. Data as of 4 Nov 2026.
Deals
3
distinct rounds
Companies
3
backed
Active span
2023–2026
4 yrs
Total round €
€17M
sum of rounds joined
Deals by year
distinct rounds / yearOKG Capital — deals by year — interactive chart.
Data table
| OKG Capital — deals by year | |
|---|---|
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Top sectors
by dealsOKG Capital — top sectors — interactive chart.
Data table
| OKG Capital — top sectors | |
|---|---|
| Healthtech | 2 |
| Cleantech | 1 |
Stages
by dealsOKG Capital — stages — interactive chart.
Data table
| OKG Capital — stages | |
|---|---|
| Other | 2 |
| Series A | 1 |
Countries
by dealsOKG Capital — countries — interactive chart.
Data table
| OKG Capital — countries | |
|---|---|
| UK | 2 |
| Germany | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Angels4Health1
- Aurelium Ventures1
- Christoph Behn1
- Civilization Ventures1
- Cross Border Impact Ventures1
- DigitalDx Ventures1
- Eka Ventures1
- existing subscribers1
- Innovate UK grant1
- Macmillan Cancer Support1
- members of Cambridge Capital Group1
- Meridian Health Ventures (MHV)1
- Nikolas Weber1
- Oliver Diekmann1
- Qantx1
- RAW Ventures1
- We Venture Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Oxcan | UK | 1 | €11M |
| iFAST Diagnostics | UK | 1 | €5.8M |
| Halitus | Germany | 1 | €1.0M |